Flu a windfall for some drug makers, shares jump (Reuters):
On a nervous down-day in the stock market, pharma and biotech companies were the winners.
One-day gain for large pharmaceutical companies:
Roche: 3.51% (who markets Tamiflu)
GlaxoSmithKline: 5.67%
Baxter (BAX): 2.4%
Sanofi-Aventis: 2.43%
Gilead Sciences (GILD): 3.78% (original inventor of Tamiflu)
One-day gain for smaller, biotech companies developing vaccines:
Novavax (NVAX): 78%
BioChryst Pharmaceuticals:75%
I seem to recall the name Baxter from a different piece of news... Does anyone remember this in February? "Baxter: Product contained live bird flu virus (Toronto Sun)"
戦争の経済学
-
ArmstrongEconomics.com, 2/9/2014より:
戦争の経済学
マーティン・アームストロング
多くの人々が同じ質問を発している- なぜ今、戦争の話がでるのか?
答えはまったく簡単だ。何千年もの昔までさかのぼる包括的なデータベースを構築する利点の一つは、それを基にいくつもの調査研究を行...
10 years ago
0 comments:
Post a Comment